Rockwell Medical (RMTI) Revenue (2010 - 2026)

Rockwell Medical's Revenue history runs 17 years deep, the most recent figure standing at $17.3 million for Q1 2026.

• Quarterly Revenue fell 8.34% year-over-year to $17.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $67.7 million (down 30.75% YoY) and the FY2025 annual result came in at $69.3 million, down 31.76% from the prior year.
• Revenue was $17.3 million for Q1 2026 at Rockwell Medical, down from $18.3 million in the prior quarter.
• Across five years, Revenue topped out at $28.3 million in Q3 2024 and bottomed at $15.9 million in Q3 2025.
• A 5-year average of $20.3 million and a median of $18.9 million in 2025 frame the typical range for Revenue.
• Annual changes were most pronounced in 2024 — Revenue soared 42.88% — and 2025, when it tumbled 43.75%.
• Rockwell Medical's Revenue stood at $19.3 million in 2022, then increased by 14.39% to $22.1 million in 2023, then increased by 11.64% to $24.7 million in 2024, then slipped by 25.62% to $18.3 million in 2025, then dropped by 5.51% to $17.3 million in 2026.
• Business Quant data shows RMTI's Revenue at $17.3 million in Q1 2026, $18.3 million in Q4 2025, and $15.9 million in Q3 2025.